TIEDEMANN ADVISORS, LLC - AZURRX BIOPHARMA INC ownership

AZURRX BIOPHARMA INC's ticker is AZRX and the CUSIP is 05502L105. A total of 17 filers reported holding AZURRX BIOPHARMA INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
TIEDEMANN ADVISORS, LLC ownership history of AZURRX BIOPHARMA INC
ValueSharesWeighting
Q2 2020$57,000
+54.1%
63,4600.0%0.00%
+50.0%
Q1 2020$37,000
-88.2%
63,460
-79.1%
0.00%
-86.7%
Q4 2019$314,000
+726.3%
303,014
+377.5%
0.02%
+650.0%
Q3 2019$38,000
-62.7%
63,460
+5.8%
0.00%
-60.0%
Q2 2019$102,000
-29.7%
60,0000.0%0.01%
-28.6%
Q1 2019$145,000
+98.6%
60,0000.0%0.01%
+75.0%
Q4 2018$73,000
-52.6%
60,0000.0%0.00%
-55.6%
Q3 2018$154,00060,0000.01%
Other shareholders
AZURRX BIOPHARMA INC shareholders Q1 2019
NameSharesValueWeighting ↓
Pensionmark Financial Group, LLC 80,000$90,0000.03%
PARSONS CAPITAL MANAGEMENT INC/RI 178,203$161,0000.02%
Waldron Private Wealth LLC 69,835$63,0000.01%
ARDSLEY ADVISORY PARTNERS LP 30,000$27,0000.01%
Patriot Financial Group Insurance Agency, LLC 15,250$14,0000.01%
TIEDEMANN ADVISORS, LLC 63,460$57,0000.00%
Squarepoint Ops LLC 39,439$36,0000.00%
Tower Research Capital LLC (TRC) 15,557$14,0000.00%
BlackRock Inc. 15,332$14,0000.00%
Renaissance Technologies 143,500$130,0000.00%
View complete list of AZURRX BIOPHARMA INC shareholders